Soctera, Inc.

Soctera is developing the world’s first aluminum nitride-based power amplifier. These amplifiers will allow higher power operation than other material platforms, such as gallium nitride or silicon. Higher power translates to an increase in the distance a wireless signal can travel. This is of value in markets such as base stations and military radar systems. Soctera plans to expand from this initial product and develop the aluminum nitride platform as the future of high-frequency, high-power electronics.

Soctera spun out of an engineering lab at Cornell University in Ithaca, NY.

IpiNovyx Bio Inc.

IpiNovyx is a biopharmaceutical company that aims to transform the ways autoimmune and inflammatory are treated through a reversable, ultra-potent and non-toxic approach.

Convergent Therapeutics, Inc.

Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company’s proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University.

 

Sedec Therapeutics, Inc.

Sedec is a therapeutics company that aims to inhibit key factors in a subset of CD4+ T cells to decrease inflammation. This approach can be used to treat T cell-mediated autoimmune disorders, such as inflammatory bowel disease.

Lo Bio Life Sciences LLC

Lo Bio has developed a rapid and low-cost approach to separate red blood cells from plasma using magnetic beads and a portable separator. This approach yields highly pure plasma from small volumes, takes less than two minutes, and can be applied for diagnostic tests for COVID-19, HIV 1 / 2, and HCV.

Kanvas Bioscience, Inc.

Kanvas Biosciences, Inc. has developed an approach to identify dense microbial organisms at a single-microbe resolution through spatially resolved metagenomics and a combination of multi-spectral imaging and innovative software. This technology circumvents metagenomic sequencing and can be applied as a diagnostic to identify microbial communities or study tumor-microbiome relationships.

RadRite

Radrite is a non-profit, modern software company that has created the first mobile app for radiology CDSM. This software is inexpensive and easy for clinicians to integrate into their current practice.

Intermix Performance Materials, Inc.

Intermix Performance Materials’ multi-block compatibilizer additive technology increases the efficient and cost-effective recycling of post-consumer mixed plastic waste and produces higher quality resultant resins.